A Survey of Financial Toxicity in Rural Cancer Patients
NCT04032483 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26
Last updated 2024-03-13
Summary
This project aims to elucidate the prevalence of financial toxicity, identify significant risk factors for toxicity, and understand the burdens of the specific St. Johnsbury rural population. These data will drive future, larger studies to investigate how to alleviate the burden of financial toxicity, especially in vulnerable patient populations.
Conditions
- Financial Toxicity
Sponsors & Collaborators
-
Dartmouth-Hitchcock Medical Center
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-01-08
- Primary Completion
- 2023-12-28
- Completion
- 2024-03-01
Countries
- United States
Study Locations
More Related Trials
-
LungTech: Stereotactic Body Radiotherapy (SBRT) of Inoperable Centrally Located NSCLC
NCT01795521 ·Status: UNKNOWN ·Phase: PHASE2
-
Financial Toxicity (FT) for Radiotherapy (RT) Patients in Italy: a yAIRO (Associazione Italiana Radioterapia e Ocologia Clinica) Multicenter Study
NCT07175350 ·Status: RECRUITING
-
Circulating Cytokines as Predictors of Radiation Induced Pulmonary Toxicity
NCT00178230 ·Status: COMPLETED
-
Avoiding Cardiac Toxicity in Lung Cancer Patients Treated With Curative-intent Radiotherapy
NCT03645317 ·Status: UNKNOWN ·Phase: NA
-
Assessment of Early Radiation Oncology Involvement Alongside Standard Oncologic Care in the Managemet
NCT05351294 ·Status: SUSPENDED ·Phase: PHASE3
-
Stereotactic Ablative Body Radiotherapy (SABR) for Oligometastases
NCT02933242 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung Cancer
NCT01899989 ·Status: COMPLETED ·Phase: PHASE1
-
Radiation-induced Cardiac Toxicity After Non-small Cell Lung Cancer Radiotherapy
NCT04867564 ·Status: UNKNOWN
-
Impact of a Process Optimizing the Decision to Continue or Stop Cancer Treatments in Patients With Advanced Non-small Cell Lung Cancer.
NCT04823377 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Tumor Hypoxia of Head-and-neck Cancer Underwent Radiation Therapy Measured With F-18-FMISO
NCT00180180 ·Status: COMPLETED
-
Prospective Study on Factors Predicting Chemo-Radiotherapy Induced Pulmonary and Esophageal Injury
NCT00631839 ·Status: UNKNOWN
-
FMISO-based Adaptive Radiotherapy for Head and Neck Cancer
NCT05348486 ·Status: RECRUITING ·Phase: NA
-
Immunotherapy SBRT Sensitization of the Programmed Death-1 (PD-1) Effect
NCT03825510 ·Status: COMPLETED ·Phase: PHASE2
-
Stereotactic Body Radiation Therapy (SBRT) for Lung Tumors
NCT00632281 ·Status: COMPLETED ·Phase: NA
-
A Phase I/II Trial of Stereotactic Body Radiation Therapy
NCT00591838 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Feasibility Study of the Use of Actigraphy to Determine Prognosis in Patients With Advanced Cancer
NCT03283683 ·Status: COMPLETED
-
Isotoxic Intensity Modulated Radiotherapy (IMRT) in Stage III Non Small Cell Lung Cancer (NSCLC) - A Feasibility Study
NCT01836692 ·Status: COMPLETED ·Phase: NA
-
Distributed Learning of Edic and CardIac Dose Effects in Lung Cancer
NCT06329648 ·Status: NOT_YET_RECRUITING
-
Analysis of Percutaneous Ablations for Cancer Treatment
NCT01563679 ·Status: COMPLETED
-
Study of the Efficacy of SBRT on Unresectable Peripheral Primary Tumor
NCT02400424 ·Status: TERMINATED ·Phase: NA
-
Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Cancer of the Larynx
NCT00002496 ·Status: COMPLETED ·Phase: PHASE3
-
Adaptative MR-Guided Stereotactic Body Radiotherapy of Liver Tumors
NCT04242342 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Feasibility Study On Continuous Adaptive [18f]Fdg-Pet-Guided Radiotherapy For Head and Neck Cancer
NCT01208883 ·Status: COMPLETED ·Phase: PHASE1
-
Stereotactic Volumetric Radiotherapy in Prostate Cancer
NCT02423889 ·Status: COMPLETED ·Phase: PHASE2
-
Remote Temperature Monitoring of Patients At Risk for Developing Fever
NCT06752512 ·Status: RECRUITING ·Phase: NA